Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 10 October 1975:
Vol. 190. no. 4210, pp. 163 - 165
DOI: 10.1126/science.1166308
Prev | Table of Contents | Next

Articles

Science, Vol 190, Issue 4210, 163-165
Copyright © 1975 by American Association for the Advancement of Science

articles

Somatostatin suppresses secretin and pancreatic exocrine secretion

G Boden, MC Sivitz, OE Owen, N Essa-Koumar, and JH Landor

Somatostatin, a hypothalamic peptide, suppresses hydrochloric acid-stimulated release of secretin, pancreatic flow rate, and bicarbonate and protein secretion in fasted, conscious dogs. It also reduces nonstimulated pancreatic exocrine secretion but does not affect basal secretin concentrations. Suppression of HCl-stimulated secretin release is complete, whereas pancreatic flow rate and bicarbonate and protein secretions are only partially inhibited. The action of somatostatin is rapid in onset and quickly reversible.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Optimising the treatment of upper gastrointestinal fistulae.
I Gonzalez-Pinto and E M. Gonzalez (2001)
Gut 49, iv21-28
   Abstract »    Full Text »    PDF »
Somatostatin Inhibits Akt Phosphorylation and Cell Cycle Entry, But Not p42/p44 Mitogen-Activated Protein (MAP) Kinase Activation in Normal and Tumoral Pancreatic Acinar Cells.
S. Charland, M.-J. Boucher, M. Houde, and N. Rivard (2001)
Endocrinology 142, 121-128
   Abstract »    Full Text »    PDF »
Inhibitory and Stimulatory Effects of Somatostatin on Two Human Pancreatic Cancer Cell Lines: A Primary Role for Tyrosine Phosphatase SHP-1.
N. Douziech, E. Calvo, Z. Coulombe, G. Muradia, J. Bastien, R. A. Aubin, A. Lajas, and J. Morisset (1999)
Endocrinology 140, 765-777
   Abstract »    Full Text »
Treatment of Orthostatic Hypotension with Midodrine and Octreotide.
R. D. Hoeldtke, G. G. Horvath, K. D. Bryner, and G. R. Hobbs (1998)
J. Clin. Endocrinol. Metab. 83, 339-343
   Abstract »    Full Text »
Prevention of Postprandial Hypotension with Somatostatin.
R. D. HOELDTKE, T. M. O'DORISIO, and G. BODEN (1985)
Ann Intern Med 103, 889-890
   Abstract »    PDF »
Pancreatic Polypeptide: A Review.
J. Lonovics, P. Devitt, L. C. Watson, P. L. Rayford, and J. C. Thompson (1981)
Arch Surg 116, 1256-1264
   Abstract »    PDF »
Splanchnic somatostatin: a hormonal regulator of nutrient homeostasis.
V Schusdziarra, E Zyznar, D Rouiller, G Boden, J. Brown, A Arimura, and R. Unger (1980)
Science 207, 530-532
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)